Cornelis Punt

9PUBLICATIONS
68CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer diagnosisCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 10, 2025
Morning administration of anthracyclines is associated with a lower risk of cancer therapy-related cardiac dysfunction.

Markella I Printezi, Arco J Teske, Nicolaas P A Zuithoff

|Jul 17, 2024
Predicting Benefit From FOLFOXIRI Plus Bevacizumab in Patients With Metastatic Colorectal Cancer.

Marinde J G Bond, Maarten van Smeden, Koen Degeling

|Mar 07, 2022
External validation of the MSKCC nomogram to estimate five-year overall survival after surgery for stage I-III colon cancer in a Dutch population.

Marinde J G Bond, Patricia A H Hamers, Geraldine R Vink

|Oct 21, 2020
Comparing Conventional Chemotherapy to Chronomodulated Chemotherapy for Cancer Treatment: Protocol for a Systematic Review.

Aoife B Kilgallen, Urška Štibler, Markella I Printezi

|Jan 26, 2020
Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial.

Steve Boudewijns, Martine Bloemendal, Nienke de Haas

Pageof 2